Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18664 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Ibrahim Tohidi-Esfahani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Ibrutinib changed the landscape of treatment in Waldenström macroglobulinaemia (WM) with excellent responses; however, there are high rates of dose reduction due to adverse events. The impact of this reduced dosing is unclear with regards to outcomes. Sarosiek and colleagues provide valuable data in a very large retrospective study demonstrating that dose reduction is effective in managing adverse events in the majority, with equivalent, if not better, outcomes than those without dose reductions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Haematology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Judith Trotman
Zitieren
APA
Tohidi-Esfahani, I., & Trotman, J. (2023). Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more. British Journal of Haematology. https://doi.org/10.1111/bjh.18664
Vancouver
Tohidi-Esfahani I, Trotman J. Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more. British Journal of Haematology. 2023. doi:10.1111/bjh.18664
BibTeX
@article{TohidiEsfahani2023,
author = {Tohidi-Esfahani, Ibrahim and Trotman, Judith},
title = {Dose of ibrutinib in Waldenström macroglobulinaemia: Less can be more},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18664}
}
EUVIMED